ViGenCell Inc (308080)

Currency in KRW
7,920
+60(+0.76%)
Closed·
308080 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7,4007,920
52 wk Range
2,30517,360
Key Statistics
Bid/Ask
7,900.00 / 7,920.00
Prev. Close
7,860
Open
7,850
Day's Range
7,400-7,920
52 wk Range
2,305-17,360
Volume
183.26K
Average Volume (3m)
1.94M
1-Year Change
237.7399%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
308080 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

ViGenCell Inc Company Profile

ViGenCell Inc. provides immune cell therapy in South Korea. It develops ViTier, an antigen-specific killer T cell therapy, such as VT-EBV-N for NK/T Lymphoma indications and VT-Tri(1)-A for AML indications; ViMedier, a cord blood-derived myeloid suppressor cell therapy, including VM-GD for GvHD indications and VM-AD for atopic dermatitis indications; and ViRanger, an off-the-shelf allogenic universal T cell gene therapy comprising VR-CAR and VR-GDT for hepatoma and leukemia indications. The company was founded in 2013 and is based in Seoul, South Korea.

Compare 308080 to Peers and Sector

Metrics to compare
308080
Peers
Sector
Relationship
P/E Ratio
−12.8x−6.8x−0.5x
PEG Ratio
−0.46−0.180.00
Price/Book
2.8x3.4x2.6x
Price / LTM Sales
577.6x12.0x3.3x
Upside (Analyst Target)
-0.0%45.5%
Fair Value Upside
Unlock6.3%5.1%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-132.00 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

308080 Income Statement

People Also Watch

54,600.00
437730
-1.97%
14,100
090710
-1.47%
117,800.00
475830
-1.67%
45,600
281820
+0.22%
67,300.00
466100
+0.75%

FAQ

What Is the ViGenCell (308080) Stock Price Today?

The ViGenCell stock price today is 7,920

What Stock Exchange Does ViGenCell Trade On?

ViGenCell is listed and trades on the KOSDAQ.

What Is the Stock Symbol for ViGenCell?

The stock symbol for ViGenCell is "308080."

What Is the ViGenCell Market Cap?

As of today, ViGenCell market cap is 161.12B.

What Is ViGenCell's Earnings Per Share (TTM)?

The ViGenCell EPS (TTM) is -650.72.

From a Technical Analysis Perspective, Is 308080 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has ViGenCell Stock Split?

ViGenCell has split 1 times.

How Many Employees Does ViGenCell Have?

ViGenCell has 64 employees.

What is the current trading status of ViGenCell (308080)?

As of Feb 12, 2026, ViGenCell (308080) is trading at a price of 7,920, with a previous close of 7,860. The stock has fluctuated within a day range of 7,400 to 7,920, while its 52-week range spans from 2,305 to 17,360.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.